Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
13,369,308
-
Share change
-
+1,604
-
Total reported value
-
$524,711,784
-
Price per share
-
$39.60
-
Number of holders
-
59
-
Value change
-
+$64,000
-
Number of buys
-
1
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q4 2013
As of 31 Dec 2013,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,369,308 shares.
The largest 10 holders included
Polaris Venture Management Co IV LLC, ORBIMED ADVISORS LLC, FMR LLC, Deer VII & Co. Ltd., JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, QVT Financial LP, ADAGE CAPITAL PARTNERS GP LLC, PRICE T ROWE ASSOCIATES INC /MD/, and BlackRock Advisors LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.